SIRT3 and Alzheimer disease: Upregulation of SIRT3 expression in AD not only reduces ROS damage to mitochondrial structure by deacetylation and activation of SOD2 (Jacobs et al., 2008; Cho et al., 2009), but also participates in the regulation of mitochondrial quality (Kincaid and Bossy-Wetzel, 2013).